This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

NeoGenomics Appoints Dr. Barbara Chaitin As Director Of Surgical Pathology And Medical Director For Its Florida Lab

Stocks in this article: NGNM

FT. MYERS, Fla., Jan. 4, 2012 /PRNewswire/ --  NeoGenomics, Inc. (NASD OTC BB: NGNM), a leading provider of cancer-focused genetic testing services, announced today the appointment of Dr. Barbara Chaitin as Director of Surgical Pathology for NeoGenomics Laboratories and Medical Director of the Fort Myers, Florida laboratory. 

Dr. Chaitin was recently the Director of Esoteric Services, and Chair of the Solid Tumor Committee, at AmeriPath, a division of Quest Diagnostics Inc.  Prior to that time, she was National Medical Director and Head of Solid Tumor Services at Genzyme Genetics in New York City.  Dr. Chaitin's professional experience also includes service as Associate Medical Director at IMPATH Laboratories in New York City and Bender Laboratory in Albany, New York.  Early in her career, she served as a Forensic Pathologist for New York State, and as an Attending Pathologist and Assistant Professor of Pathology at New York University Medical School and Albert Einstein College of Medicine.

Dr. Chaitin attended Albert Einstein College of Medicine, completed her Anatomic and Clinical Pathology Residency at University of California in San Francisco, and completed Fellowships in Surgical Pathology at Stanford University Medical Center and at MD Anderson Cancer Center.  She is Board certified in both Forensic Pathology and Anatomic Pathology. 

Doug VanOort, NeoGenomics Chairman and CEO commented, "Dr. Chaitin brings a wealth of experience and valuable expertise to NeoGenomics.  We have strong expertise in the application of molecular genetics in oncology and hematology, and our clients are requesting that we continue to enhance our capabilities for solid tumor pathways and disease.  We are looking forward to Dr. Chaitin's medical leadership as we expand our immunohistochemistry offering and introduce new FISH and molecular tests targeted at solid tumor pathology.  We are excited to welcome Dr. Chaitin to our Medical Team and to our company."

1 of 2

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 17,959.44 +154.64 0.87%
S&P 500 2,078.54 +7.89 0.38%
NASDAQ 4,781.4240 +16.0440 0.34%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs